Is Tilray Too Dangerous?

“Tilray is too dangerous,” said CNBC’s “Mad Money” host Jim Cramer. “It is a spec stock that is losing money, and we don’t recommend stocks that are losing money.” Cramer isn’t the only one shying away from the Canadian cannabis producer. Kerrisdale Capital called the company a “failing cannabis player” in a recent report. We are short shares of Tilray Brands, a $2.4bn failing Canadian cannabis player running a familiar playbook for unsuccessful businesses trading in the public markets: given […]

The post Is Tilray Too Dangerous? appeared first on Cannabis | Weed | Marijuana | News.

What is Public Health?

What is “public health?” Since 2020, the term has entered the mainstream, but public health was around long before covid. Canadian politicians crafted cannabis legalization with “public health” goals in mind. Instead of the traditional argument for legal cannabis, which is that you have a right to your body. But let’s give them the benefit of the doubt. Like most things in life, let’s apply the 80/20 rule. 80% of “public health” are hapless bureaucrats who believe they are improving […]

The post What is Public Health? appeared first on Cannabis | Weed | Marijuana | News.

Farm-to-Table Cannabis Coming to Victoria

Last Thursday, the City of Victoria approved rezoning for its first farm-to-table cannabis operation. A majority of the council voted to amend bylaws so one facility can house four different Health Canada licenses. The Victoria Cannabis Company will have a nursery, micro-cultivation, processing and sales all in one spot, located at 340 Mary St. The City of Victoria approved the rezoning despite another cannabis retailer within 400 metres. But Councillor Jeremy Caradonna justified bending the rules since a farm-to-table site […]

The post Farm-to-Table Cannabis Coming to Victoria appeared first on Cannabis | Weed | Marijuana | News.

State of the New York Cannabis Market

What is the state of the New York cannabis market? Earlier this week, the Office of Cannabis Management (OCM) approved regulations to boost the New York cannabis market. When New York first legalized cannabis in 2021, analysts expected a $4 billion market. Two years later, they’re generating a measly $12 million with only 20 legal stores. Compared to neighboring states, it’s clear the New York cannabis market is underperforming. But now the rules have changed. Regulators are now allowing multi-state […]

The post State of the New York Cannabis Market appeared first on Cannabis | Weed | Marijuana | News.

Canada’s Recession (& the 4-Step Cannabis Solution)

What is the four-step cannabis solution to Canada’s recession? Canada’s recession is here, masked only by the large influx of immigrants keeping the job numbers up. But when you control for population growth, Canada is in an economic recession. What’s the solution? Whether it’s left-wing parties calling for “stimulus” or right-wing parties calling for “austerity,” you won’t find solutions listening to the elites and gatekeepers responsible for this mess. Too many dollars are chasing too few goods. There aren’t enough […]

The post Canada’s Recession (& the 4-Step Cannabis Solution) appeared first on Cannabis | Weed | Marijuana | News.

Republican Legislators Call on DEA To Reject Recommendation To Reschedule Cannabis

A group of Republican legislators recently sent a letter to the Drug Enforcement Administration (DEA) asking for the agency to reject the recent recommendation to reschedule cannabis, which was suggested by the Department of Health and Human Services (HHS) on Aug. 29.

The list included lead authors Sen. James Lankford (Oklahoma) and Rep. Pete Sessions (Texas), along with signatures from Sen. M. Michael Rounds (South Dakota), Sen. James E. Risch (Idaho), Sen. Marsha Blackburn (Tennessee), Sen. Mike Crapo (Idaho), Sen. Ted Budd (North Carolina), Sen. Markwayne Mullin (Oklahoma), Sen. Tom Cotton (Arkansas), Rep. Chuck Edwards (North Carolina), Rep. Robert B. Aderholt (Alabama), Rep. Hal Rogers (Kentucky), Rep. Earl L. Carter (Georgia), and Rep. Andy Biggs (Arizona).

“The recommendation to remove marijuana from the DEA’s list of dangerous Schedule I drugs is not based on science—it’s based on an irresponsible pro-pot agenda,” Lankford wrote on social media and sharing the letter.

We write to urge the Drug Enforcement Administration (DEA) to reject any petition or request to remove marijuana from Schedule I of the Controlled Substances Act (CSA). Any effort to reschedule marijuana should be based on proven facts and science—not popular opinion, changes in state laws, or the preferred policy of an Administration,” the letter states.

One of the letter’s arguments against rescheduling cannabis cites the National Institute on Drug Abuse (NIDA), stating that “30% of marijuana users have marijuana use disorder, who are severely addicted to the drug.” The authors mention the rise in THC in products today compared to 25 years ago. “These facts indicate that marijuana has a high potential for abuse and that the risk is only increasing,” they added. Last month, NIDA reportedly signed off on the HHS recommendation.

The letter authors also make claims that cannabis “does not have a currently accepted medical use.” While it mentions the single Food and Drug Administration (FDA)-approved cannabis-derived drug (Epidiolex), and three synthetic cannabis drugs (Marinol, Syndros, and Cesamet), the letter states that substances only have medical value if they are approved by the FDA. The authors also added that previously in 2016, the DEA rejected two petitions for cannabis rescheduling, and the HHS agreed. “The rejection letter stated, ‘At this time, the known risks of marijuana use have not been shown to be outweighed by specific benefits in well-controlled clinical trials that scientifically evaluate safety and efficacy,’” the letter stated. “We believe this analysis is still true today. In fact, HHS recommended at the time that DEA reject these petitions and that marijuana remain in Schedule I.”

The signatories state that nothing has changed over the past seven years, and believe that “the situation has gotten worse,” citing an increase in child hospitalizations due to accidental cannabis consumption, and the negative effects of cannabis on youth teenagers.

“It is irresponsible for HHS to recommend that marijuana be removed from Schedule I,” they concluded. “It would also be irresponsible for DEA to act on this recommendation. Our country relies on DEA to enforce our nation’s drug laws. We ask you to uphold your mission by rejecting any effort to remove marijuana from Schedule I.”

The letter fails to mention the evidence of cannabis’ medical benefits for countless conditions, or its part in the War on Drugs and countless people affected by its Schedule I status.

Now that the HHS has provided the details of its recommendation to move cannabis from a Schedule I to Schedule III substance, the DEA will also conduct a scientific review.

These Republican legislators believe that cannabis should remain a Schedule I substance, which labels it as having no medical value, high potential for abuse, and places it among other substances including heroin, LSD, ecstasy, and more. Legislators who have continued to support cannabis in congress, such as Rep. Earl Blumenauer, believe that this is just the beginning. “This is a step in the right direction but it is not sufficient. I hope it is followed by more significant reforms. This is long overdue,” he said in a statement.

NORML Deputy Director Paul Armentano published an article explaining why rescheduling cannabis isn’t enough. “While some entities, particularly those involved in the commercial cannabis industry, have lauded the proposed change as a ‘giant’ step forward, others—like myself—have been far more restrained,” Armentano stated. “First, reclassifying cannabis to a lower schedule within the CSA continues to misrepresent the plant’s safety relative to other controlled substances such as anabolic steroids and ketamine (Schedule III), benzodiazepines (Schedule IV), or even alcohol, which is unscheduled.”

NORML has previously called for cannabis to be completely descheduled, and Armentano wrote that this is still the case. After the HHS recommendation news was published, Armentano discussed the topic with outlets such as The Associated Press, The Washington Post, and more. “Tobacco and alcohol are not in the Controlled Substances Act,” he told CNN. “Those substances are well recognized to pose far greater hazards to health than cannabis. We should treat marijuana [under the federal scheduling system] equally.”

The post Republican Legislators Call on DEA To Reject Recommendation To Reschedule Cannabis appeared first on High Times.

Cannabis Legalization Improves Mental Health?

Does cannabis legalization improve mental health? According to a recent study published in Health Economics, the answer is yes, probably. The study found states that legalized cannabis saw admissions for mental health treatment drop. But is this merely a correlation?  Many studies suggest cannabis worsens or even causes mental health problems. Often, these studies are observational, non-replicable, and thus, merely the opinions of particular researchers with a Science™ label. When the study suggests cannabis worsens mental health, the researchers call for […]

The post Cannabis Legalization Improves Mental Health? appeared first on Cannabis | Weed | Marijuana | News.

Ted Smith on Cannabis in Canada

Last week, CLN chatted with long-time cannabis activist and Cannabis Digest contributor Ted Smith on the state of cannabis in Canada. Ted is the founder and owner of the Victoria Cannabis Buyer’s Club (VCBC), Canada’s longest-running (and last remaining) compassionate club. Despite helping thousands of patients, the Canadian and B.C. governments consider Ted a criminal. “It’s frustrating,” says Ted by phone. Especially since other jurisdictions – like legal U.S. states – are legalizing consumption spaces. In Canada, cannabis civil disobedience has always […]

The post Ted Smith on Cannabis in Canada appeared first on Cannabis | Weed | Marijuana | News.

Consequences of Rescheduling Cannabis

What are the consequences of rescheduling cannabis in the United States? Last week, the federal Department of Health and Human Services (HHS) sent a memo to the Drug Enforcement Administration (DEA) recommending a change in how they schedule cannabis. The herb is currently a Schedule 1 drug, meaning it has a high potential for abuse and no medical value. It shares this category with heroin. The recommendation to change cannabis to Schedule 3 isn’t legalization, but it makes cannabis research […]

The post Consequences of Rescheduling Cannabis appeared first on Cannabis | Weed | Marijuana | News.

10 Things Wrong with the Latest Cannabis Traffic Study

We have yet another study claiming that cannabis-related traffic injuries have increased since Canada legalized cannabis. The research, published in JAMA Network Open, looked at cannabis and emergency room visits for traffic injuries between 2010 and 2021 in Ontario. “Our data is raising concern about a growing problem of cannabis impairment and severe road injuries,” said lead author Dr. Daniel Myran. “Since 2010, there has been a very, very large increase in cannabis involvement and traffic injury visits in Ontario.” […]

The post 10 Things Wrong with the Latest Cannabis Traffic Study appeared first on Cannabis | Weed | Marijuana | News.